Hochschulschrift
Neurological complications associated with cancer immunotherapies - allogeneic stem cell transplantation, immune checkpoint inhibition, and CAR T cell therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
XI, 268 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Enthält Zeitschriftenaufsätze
Albert-Ludwigs-Universität Freiburg, Dissertation, 2022
- Schlagwort
-
T-Lymphozyt
Immun-Checkpoint
Immuntherapie
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg im Breisgau
- (wann)
-
October 2022
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
- 11.06.2025, 13:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- October 2022
Ähnliche Objekte (12)
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Tuning the performance of CAR T cell immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Development of NK cell-based cancer immunotherapies through receptor engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Tuning the performance of CAR T cell immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Development of NK cell-based cancer immunotherapies through receptor engineering
A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies
Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Tuning the performance of CAR T cell immunotherapies
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Development of NK cell-based cancer immunotherapies through receptor engineering